Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation
Authors:
Open Access
- 1 March 1996
- journal article
- Published by American Society of Hematology in Blood
- Vol. 87 (5) , 2020-2028
Abstract
CD36 is an 88-kD integral membrane glycoprotein expressed on monocytes, platelets, and certain microvascular endothelium serving distinct cellular functions both as an adhesive receptor for thrombospondin, collagen, and Plasmodium falciparum-infected erythrocytes, and as a scavenger receptor for oxidized low-density lipoprotein and apoptotic neutrophils. In this study, we examined the expression of CD36 during in vitro differentiation of peripheral blood monocytes into culture- derived macrophages. Steady-state mRNA levels of CD36 showed a transient eightfold increase during monocyte-to-macrophage differentiation, peaking at the early macrophage stage (days 3 or 4 in culture), following a gradual decrease back to baseline levels by the mature macrophage stage (days 7 or 8 in culture). Immunoblotting with monoclonal antibodies to CD36 supported this transient, yet significant (8- to 10-fold) increase in total protein levels of CD36. The increased CD36 protein was observed at the plasma membrane, whereas an intracellular pool of CD36 was also detected from day 2 to day 6 in culture through indirect immunofluorescence. A concomitant twofold increase in the cells' ability to bind 125I-thrombospondin at the early macrophage stage (day 4) verified the functional competency of the plasma membrane localized CD36, and supported the presence of an intracellular pool of CD36. The in vitro differentiated macrophages as well as alveolar macrophages remained responsive to macrophage colony- stimulating factor (M-CSF), a known transcriptional regulator of monocyte CD36. The M-CSF-induced macrophages resulted in enhanced foam cell formation, which was inhibitable with monoclonal antibodies to CD36. Thus, the transient expression of CD36 during monocyte-to- macrophage differentiation, and the ability of M-CSF to maintain macrophage CD36 at elevated levels, may serve as a critical process in dictating the functional activity of CD36 during inflammatory responses and atherogenesis.Keywords
This publication has 16 references indexed in Scilit:
- Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2.Genes & Development, 1995
- CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis.Journal of Experimental Medicine, 1995
- CD36 Induction on Human Monocytes upon Adhesion to Tumor Necrosis Factor-activated Endothelial CellsJournal of Biological Chemistry, 1995
- Recombinant GST/CD36 Fusion Proteins Define a Thrombospondin Binding DomainJournal of Biological Chemistry, 1995
- Analysis of CD36 Binding Domains: Ligand Specificity Controlled by Dephosphorylation of an EctodomainScience, 1993
- Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor.Journal of Biological Chemistry, 1992
- Human monocyte colony-stimulating factor enhances the clearance of lipoproteins containing apolipoprotein B-100 via both low density lipoprotein receptor-dependent and -independent pathways in rabbits.Journal of Biological Chemistry, 1990
- Plasmodium falciparum Sequestration: OKM5 Antigen (CD36) Mediates Cytoadherence of Parasitized Erythrocytes to a Myelomonocytic Cell LineThe Journal of Infectious Diseases, 1988
- Induction of tissue transglutaminase in human peripheral blood monocytes.Journal of Experimental Medicine, 1984
- Immune-complex-induced transglut aminase activation: Its role in the Fc-receptor-mediated transmembrane effect on peritoneal macrophagesMolecular Immunology, 1981